Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy

NCT04813380 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

OTHER_GOV

Sponsor class

Conditions

Effects of Immunotherapy

Interventions

OTHER: Sublingual immunotherapy

Sponsor

Zagazig University